Oxycodone/Naloxone (OXN) Combination in Moderate to Severe Non-malignant Pain
NCT01167127
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
113
Enrollment
INDUSTRY
Sponsor class
Conditions
Pain
Interventions
DRUG:
Oxycodone hydrochloride and naloxone hydrochloride combination, prolonged release
Sponsor
Mundipharma Pharmaceuticals B.V.